Published in Heart Rhythm on May 24, 2007
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol (2015) 1.56
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol (2011) 1.44
Calsequestrin 2 and arrhythmias. Am J Physiol Heart Circ Physiol (2011) 1.08
Current topics in catecholaminergic polymorphic ventricular tachycardia. J Arrhythm (2015) 1.08
Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2012) 1.06
Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia. Heart Vessels (2010) 1.05
Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice. Heart Rhythm (2010) 1.03
Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome. Clin Res Cardiol (2012) 0.94
CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. Acta Pharmacol Sin (2010) 0.88
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. J Cardiovasc Electrophysiol (2010) 0.86
Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia. Pediatr Cardiol (2012) 0.85
Power and pitfalls of using transgenic mice to optimize therapy for CPVT: a need for prospective placebo-controlled clinical trials in genetic arrhythmia disorders. Heart Rhythm (2010) 0.85
Exercise training improves cardiac function and attenuates arrhythmia in CPVT mice. J Appl Physiol (1985) (2012) 0.80
Risk stratification in young patients with channelopathies. Indian Pacing Electrophysiol J (2010) 0.75
L-Type Calcium Channels Do Not Play a Critical Role in Chest Blow Induced Ventricular Fibrillation: Commotio Cordis. Cardiol Res Pract (2016) 0.75
Impaired calcium-calmodulin-dependent inactivation of Cav1.2 contributes to loss of sarcoplasmic reticulum calcium release refractoriness in mice lacking calsequestrin 2. J Mol Cell Cardiol (2015) 0.75
Catecholaminergic polymorphic ventricular tachycardia: An exciting new era. Ann Pediatr Cardiol (2016) 0.75
Calcium Signaling and Cardiac Arrhythmias. Circ Res (2017) 0.75
[Catecholaminergic polymorphic ventricular tachycardia]. Herzschrittmacherther Elektrophysiol (2012) 0.75
Calcium handling and ventricular tachyarrhythmias. Wien Med Wochenschr (2012) 0.75
Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol (2011) 3.86
Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med (2014) 3.80
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol (2013) 3.08
J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol (2008) 2.87
Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost? J Am Coll Cardiol (2012) 2.84
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm (2010) 2.79
The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol (2010) 2.56
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.56
P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol (2006) 2.47
Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol (2012) 2.40
Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J (2013) 2.29
Fever-induced Brugada pattern: how common is it and what does it mean? Heart Rhythm (2013) 2.25
Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation (2011) 2.23
Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation (2003) 2.16
Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation (2004) 2.14
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol (2012) 2.13
Inaccessibility to quinidine therapy is about to get worse. J Am Coll Cardiol (2013) 2.12
What do we know about the "malignant form" of early repolarization? J Am Coll Cardiol (2013) 2.11
To the editor--Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine. Heart Rhythm (2010) 2.10
The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm (2008) 2.07
Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm (2005) 2.07
Prevalence of fractionated electrograms in the coronary sinus: comparison between patients with persistent or paroxysmal atrial fibrillation and a control population. Heart Rhythm (2010) 2.04
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace (2013) 1.97
Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology. Heart Rhythm (2011) 1.90
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm (2004) 1.86
Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol (2004) 1.84
Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm (2011) 1.80
Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) (2003) 1.78
The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J Mol Cell Cardiol (2010) 1.78
Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm (2011) 1.74
Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J (2006) 1.73
Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol (2012) 1.70
Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation (2004) 1.70
The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol (2007) 1.69
Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm (2012) 1.67
Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol (2008) 1.64
Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol (2007) 1.63
Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling. Circulation (2004) 1.62
Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. J Am Coll Cardiol (2009) 1.61
Idiopathic left ventricular tachycardia with a right bundle branch block morphology and left axis deviation ("Belhassen type"): results of radiofrequency ablation in 18 patients. Isr Med Assoc J (2004) 1.61
Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J (2005) 1.61
Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol (2009) 1.59
Anatomically determined functional conduction delay in the posterior left atrium relationship to structural heart disease. J Am Coll Cardiol (2008) 1.58
Relationship among complex signals, short cycle length activity, and dominant frequency in patients with long-lasting persistent AF: a high-density epicardial mapping study in humans. Heart Rhythm (2011) 1.55
Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology (2011) 1.55
Supraventricular tachycardia. Med J Aust (2009) 1.54
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
Left atrial remodeling in patients with atrial septal defects. Heart Rhythm (2009) 1.52
Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol (2012) 1.50
Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol (2007) 1.50
Scar-related right atrial macroreentrant tachycardia in patients without prior atrial surgery: electroanatomic characterization and ablation outcome. Heart Rhythm (2005) 1.49
The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction. Heart Rhythm (2009) 1.48
Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia. J Cardiovasc Electrophysiol (2004) 1.48
Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant. Heart Rhythm (2012) 1.46
Characterization of catheter-tissue contact force during epicardial radiofrequency ablation in an ovine model. Circ Arrhythm Electrophysiol (2013) 1.46
Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm (2011) 1.46
The site of origin of torsade de pointes. Heart (2011) 1.45
The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia? J Cardiovasc Electrophysiol (2005) 1.44
Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm (2013) 1.44
The transesophageal echo probe may contribute to esophageal injury after catheter ablation for paroxysmal atrial fibrillation under general anesthesia: a preliminary observation. J Cardiovasc Electrophysiol (2014) 1.44
Atrial fibrillation following lung transplantation: double but not single lung transplant is associated with long-term freedom from paroxysmal atrial fibrillation. Eur Heart J (2010) 1.43
Absence of gender-based differences in the atrial and pulmonary vein substrate: a detailed electroanatomic mapping study. J Cardiovasc Electrophysiol (2014) 1.42
Radiofrequency ablation of atrioventricular nodal reentry tachycardia: a 14 year experience with 901 patients at the Tel Aviv Sourasky Medical Center. Isr Med Assoc J (2006) 1.42
Pulmonary vein paced activation sequence mapping: comparison with activation sequences during onset of focal atrial fibrillation. J Cardiovasc Electrophysiol (2002) 1.41
Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective. Heart Rhythm (2011) 1.40
Arrhythmogenic right ventricular cardiomyopathy: an unusual possible cause of arrhythmia in a 78 year old man with a 40 year history of palpitations. Isr Med Assoc J (2014) 1.39
Bipolar electrogram shannon entropy at sites of rotational activation: implications for ablation of atrial fibrillation. Circ Arrhythm Electrophysiol (2012) 1.32
Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol (2012) 1.29
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol (2004) 1.28
Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm (2007) 1.23
Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation (2003) 1.22
Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol (2003) 1.21
Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol (2006) 1.20
H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology (2010) 1.20
Catheter ablation of atrial arrhythmias: state of the art. Lancet (2012) 1.18
Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol (2007) 1.17
Atrial tachycardia arising from the coronary sinus musculature: electrophysiological characteristics and long-term outcomes of radiofrequency ablation. J Am Coll Cardiol (2005) 1.16
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace (2015) 1.13
Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect. Circulation (2003) 1.11
Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol (2010) 1.11
Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res (2007) 1.11
Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm (2008) 1.10
Transcatheter aortic valve implantation: a single-center experience of 300 cases. Isr Med Assoc J (2013) 1.09
The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol (2002) 1.08